|
PTENP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.800800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.36020000000159E-05 |
| Normal-vs-Stage2 |
2.287500E-02 |
| Normal-vs-Stage3 |
1.367430E-01 |
| Normal-vs-Stage4 |
8.572800E-01 |
| Stage1-vs-Stage2 |
5.578400E-01 |
| Stage1-vs-Stage3 |
1.214760E-01 |
| Stage1-vs-Stage4 |
7.980100E-02 |
| Stage2-vs-Stage3 |
4.917400E-01 |
| Stage2-vs-Stage4 |
2.642000E-01 |
| Stage3-vs-Stage4 |
5.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.840800E-04 |
| Normal-vs-AfricanAmerican |
4.685800E-02 |
| Normal-vs-Asian |
1.084400E-01 |
| Caucasian-vs-AfricanAmerican |
1.857170E-01 |
| Caucasian-vs-Asian |
8.080200E-01 |
| AfricanAmerican-vs-Asian |
7.954000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5848000000096E-06 |
| Normal-vs-Female |
6.035800E-01 |
| Male-vs-Female |
1.188360E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.025500E-02 |
| Normal-vs-Extreme_Weight |
1.37690000001633E-06 |
| Normal-vs-Obese |
3.060100E-02 |
| Normal-vs-Extreme_Obese |
8.695400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.874220E-01 |
| Normal_Weight-vs-Obese |
5.495800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.413400E-01 |
| Extreme_Weight-vs-Obese |
1.096290E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.381600E-01 |
| Obese-vs-Extreme_Obese |
3.410200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.530400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.054400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.17470000000364E-05 |
| Normal-vs-Age(81-100Yrs) |
3.79080000000309E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.021800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.575200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.695500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.871690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.843800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.233700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.55019999953576E-07 |
| Normal-VS-Type2 PRCC |
3.321800E-03 |
| Normal-VS-KIRP CIMP |
5.462600E-03 |
| Normal-VS-Unclassified PRCC |
7.156800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.905360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.63400004637992E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
4.420700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.70970000000059E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.913800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.880500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.264710E-03 |
| Normal-vs-N1 |
9.523000E-01 |
| Normal-vs-N2 |
6.621600E-01 |
| N0-vs-N1 |
9.398600E-03 |
| N0-vs-N2 |
1.032840E-01 |
| N1-vs-N2 |
7.299200E-01 |
|
|
